Oncologists Market Size Forecast To Achieve $25.06 Billion By 2030 With 4.4% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Growth In Market Size Of The Oncologists Market During 2026–2030?

The market size for oncologists has demonstrated consistent growth over recent years. This market is projected to expand from $20.21 billion in 2025 to $21.09 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 4.4%. Historically, this expansion has been driven by the rising incidence of cancer globally, growing demand for specialized oncology care, the expansion of hospital and clinic networks, advancements in diagnostic imaging technologies, and increasing awareness of early cancer detection.

The oncologists market size is anticipated to experience consistent expansion over the upcoming years. It is projected to reach $25.07 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.4%. This projected growth during the forecast period stems from factors such as the rise of personalized and targeted cancer treatments, the uptake of digital solutions for oncology management, advancements in immunotherapy and targeted therapy technologies, the establishment of more oncology centers in developing regions, and the escalating application of genomics and molecular diagnostics for designing treatment plans. Key developments during this period encompass the increasing integration of digital oncology platforms for managing patients, the growing incorporation of AI and machine learning in cancer detection, the expanded deployment of precision medicine and genomic profiling for tailored cancer treatment, the surging automation in preparing chemotherapy and delivering drugs, and the enhanced IoT-enabled oversight of oncology equipment and patient information.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9474&type=smp

Which Drivers Are Advancing The Oncologists Market Growth?

The increasing occurrence of cancer is anticipated to boost the oncologists market in the future. Cancer is defined as an illness where certain body cells multiply without control and extend to other areas. Cancer prevalence indicates the count of newly diagnosed cancer instances emerging within a particular population over a specific timeframe. Oncologists are medical professionals specializing in the identification and management of cancer. Their responsibilities include patient examination, cancer diagnosis, and determining appropriate treatment strategies. As an illustration, in May 2024, data from the National Cancer Institute, a US-based government agency, revealed approximately 18.1 million cancer survivors in the United States. This number is forecast to reach 22.5 million by 2032. By 2040, annual new cancer cases are expected to total 29.9 million, and cancer-related fatalities are projected to climb to 15.3 million. Consequently, the rising incidence of cancer is propelling the oncologists market.

What Are The Core Segment Classifications In The Oncologists Market?

The oncologists market covered in this report is segmented –

1) By Cancer Diagnostics And Treatment: Cancer Diagnostics, Cancer Treatment

2) By Indication: Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head And Neck Cancer, Prostate Cancer, Other Indications

3) By End Use: Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Specialty Clinics, Academia, Other End Uses

Subsegments:

1) By Cancer Diagnostics: Imaging Tests, Biopsy, Blood Tests, Molecular Diagnostics, Genetic Testing

2) By Cancer Treatment: Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Hormone Therapy, Stem Cell Transplant

What Trends Are Affecting The Growth Of The Oncologists Market?

Leading companies active in the omics-based clinical trials market are emphasizing innovative solutions, such as HiFi sequencing technology, to elevate the accuracy, speed, and depth of multi-omics data analysis, ultimately leading to enhanced trial outcomes and personalized treatment strategies. HiFi sequencing is defined as a next-generation sequencing (NGS) method that generates long, highly accurate reads through circular consensus sequencing (CCS), thereby allowing for comprehensive and precise examination of genomes, transcriptomes, and epigenomes. As an example, in October 2024, Pacific Biosciences of California Inc., a US-based biotechnology company, partnering with the Agency for Science, Technology, and Research (A*STAR), a Singapore-based research and product development agency, and Macrogen Inc., a South Korea-based biotechnology company, inaugurated a cutting-edge lab to expedite genomics innovation in Singapore utilizing advanced long-read sequencing technology. This facility allows researchers to perform sophisticated genomic studies with greater precision and rapidity. It accommodates a wide array of applications, including whole genome sequencing, transcriptomics, epigenetics, and metagenomics. The lab further encourages cooperative efforts among global scientists and local institutions, with the goal of accelerating discoveries in personalized medicine, rare disease diagnostics, and precision oncology. Additionally, it provides training programs and shared access to high-throughput sequencing infrastructure, contributing to capacity-building and innovation within the Asia-Pacific region.

Which Key Players Are Active In The Oncologists Market?

Major companies operating in the oncologists market are Abramson Cancer Center, MD Anderson Cancer Center of the University of Texas, Lilavati Hospital & Research Centre, Mount Elizabeth Hospital, Mount Miriam Cancer Hospital, Charité – Universitätsmedizin Berlin, General Electric Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., Amgen Inc., Takeda Pharmaceuticals USA Inc., Becton Dickinson and Company, Cook Medical LLC, Terumo Corporation, AngioDynamics Inc., Thermo Fisher Scientific Inc., Illumina Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Incyte Corporation, Seattle Genetics Inc.

Access The Complete Oncologists Market Report:

https://www.thebusinessresearchcompany.com/report/oncologists-global-market-report

Which Region Stands As The Largest Contributor To The Oncologists Market?

North America was the largest region in the oncologists market in 2025. The regions covered in the oncologists market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Oncologists Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=9474&type=smp

Browse Through More Reports Similar to the Global Oncologists Market 2026, By The Business Research Company

Asphalt Additives Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/asphalt-additives-global-market-report

Asphalt Pavers Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/asphalt-pavers-global-market-report

Polymer Coated Fabrics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/polymer-coated-fabrics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795